Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2024-12 · 22 (10) · 695-711
DOI: 10.6004/jnccn.2024.0061 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-12. Verfasst von Rachel Hodan und 40 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Genetic Testing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
Multigene panel testing has allowed for the detection of a growing number of inherited pathogenic/likely pathogenic variants in people at high risk of cancer, including endometrial cancer (EC). Hereditary syndromes associated with EC include Lynch syndrome, PTEN hamartoma tumor syndrome, and Peutz-Jeghers syndrome. This manuscript provides the latest recommendations from the NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric on the screening and management of EC in patients at high risk for these syndromes, as well as the advantages and limitations of multigene panel testing. This manuscript also describes recent updates to these guidelines regarding de-implementation of colon cancer screening in individuals with CHEK2 pathogenic/likely pathogenic variants, based on the most up-to-date evidence regarding the association between CHEK2 pathogenic/likely pathogenic variants and colon cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Stanford Cancer Institute.
- UC San Diego Moores Cancer Center.
- University of Wisconsin Carbone Cancer Center.
- University of Colorado Cancer Center.
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
- UCSF Helen Diller Family Comprehensive Cancer Center.
Zitieren
APA
Hodan, R., Gupta, S., Weiss, J. M., Axell, L., Burke, C. A., Chen, L. M., Chung, D. C., Clayback, K. M., Felder, S., Foda, Z., Giardiello, F. M., Grady, W., Gustafson, S., Hagemann, A., Hall, M. J., Hampel, H., Idos, G., Joseph, N., Kassem, N., …, & Diwan, Z. (2024). Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 22(10), 695-711. https://doi.org/10.6004/jnccn.2024.0061
Vancouver
Hodan R, Gupta S, Weiss JM, Axell L, Burke CA, Chen LM, et al. Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2024;22(10):695-711. doi:10.6004/jnccn.2024.0061
BibTeX
@article{Hodan2024,
author = {Hodan, Rachel and Gupta, Samir and Weiss, Jennifer M and Axell, Lisen and Burke, Carol A and Chen, Lee-May and Chung, Daniel C and Clayback, Katherine M and Felder, Seth and Foda, Zachariah and Giardiello, Francis M and Grady, William and Gustafson, Susan and Hagemann, Andrea and Hall, Michael J and Hampel, Heather and Idos, Gregory and Joseph, Nora and Kassem, Nawal and Katona, Bryson and Kelly, Kaitlyn and Kieber-Emmons, AnnMarie and Kupfer, Sonia and Lang, Katie and Llor, Xavier and Markowitz, Arnold J and Prats, Mariana Moreno and Niell-Swiller, Mariana and Outlaw, Darryl and Pirzadeh-Miller, Sara and Samadder, Niloy Jewel and Shibata, David and Stanich, Peter P and Swanson, Benjamin J and Szymaniak, Brittany M and Welborn, Jeanna and Wiesner, Georgia L and Yurgelun, Matthew B and Dwyer, Mary and Darlow, Susan and Diwan, Zeenat},
title = {Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {10},
pages = {695--711},
doi = {10.6004/jnccn.2024.0061}
}
EUVIMED